MedPath

Triamcinolone

Generic Name
Triamcinolone
Brand Names
Allernaze, Aristocort, Aristocort R, Juulissa Pharmapak, Kenalog, Kourzeq, Marcaine, Nasacort, Oracort, Oralone, Pediaderm Ta, Triaderm, Trianex, Triderm, Triesence, Triloan Suik, Tritocin, Viaderm Kc, Xipere, Zilretta
Drug Type
Small Molecule
Chemical Formula
C21H27FO6
CAS Number
124-94-7
Unique Ingredient Identifier
1ZK20VI6TY

Overview

Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate. Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular edema associated with uveitis.

Background

Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate. Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular edema associated with uveitis.

Indication

肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱,故一般不用作肾上腺皮质功能减退的替代治疗。

Associated Conditions

  • Acne
  • Acne Vulgaris
  • Acute Gouty Arthritis
  • Allergic Contact Dermatitis
  • Allergic Rhinitis (AR)
  • Allergic Skin Reaction
  • Alopecia Areata (AA)
  • Ankylosing Spondylitis (AS)
  • Aphthous Stomatitis
  • Asthma
  • Atopic Dermatitis
  • Autoimmune Hemolytic Anemia
  • Berylliosis
  • Bullous dermatitis herpetiformis
  • Chronic Eczema
  • Chronic Inflammatory Skin Diseases
  • Congenital Adrenal Hyperplasia (CAH)
  • Congenital Hypoplastic Anemia
  • Contact Dermatitis
  • Crohn's Disease (CD)
  • Dental Cavity
  • Dermatitis
  • Dermatomyositis (DM)
  • Diaper Rash
  • Discoid Lupus Erythematosus (DLE)
  • Edema of the cerebrum
  • Epicondylitis
  • Erythroderma
  • Fungal Infections
  • Fungal infectious disorders of the Beard
  • Fungal skin infection
  • Gingivitis
  • Haemorrhoids
  • Hemangiomas
  • Hypercalcemia
  • Inflammation of Mouth
  • Intertrigo
  • Itching of the Anus
  • Itching of the External Genitalia
  • Itching of the Foot
  • Itching of the genitals
  • Itching of the hand
  • Juvenile Idiopathic Arthritis (JIA)
  • Keloids Scars
  • Leukemias
  • Lichen Planus (LP)
  • Lichen simplex chronicus
  • Lymphoma
  • Macular Edema
  • Mycosis Fungoides (MF)
  • Mycotic Eczema
  • Necrobiosis lipoidica diabeticorum
  • Neurodermatitis
  • Nummular Dermatitis
  • Ocular Inflammation
  • Ophthalmia, Sympathetic
  • Oral Erosive Lichen Planus
  • Otitis Externa
  • Pemphigus
  • Pericarditis
  • Polymyositis
  • Postherpetic Neuralgia
  • Primary adrenocortical insufficiency
  • Proteinuria
  • Psoriasis Vulgaris (Plaque Psoriasis)
  • Psoriatic Arthritis
  • Psoriatic plaque
  • Pure Red Cell Aplasia
  • Purulent Wounds
  • Pyoderma caused by susceptible bacteria
  • Regional Enteritis
  • Rheumatoid Arthritis
  • Ringworm Folliculitis
  • Seborrheic Dermatitis
  • Seborrheic Dermatitis, Eczematous
  • Secondary Impetiginization
  • Secondary adrenocortical insufficiency
  • Secondary thrombocytopenia
  • Serum Sickness
  • Skin chapped
  • Stomatitis, Denture
  • Synovitis
  • Systemic Lupus Erythematosus
  • Temporal Arteritis
  • Tinea Corporis
  • Transfusion Reactions
  • Trichinosis
  • Tuberculosis (TB)
  • Ulcerative Colitis
  • Urticaria
  • Uveitis
  • Wound Infections
  • Acute Bursitis
  • Acute Multiple sclerosis
  • Acute Rheumatic heart disease, unspecified
  • Acute Tenosynovitis
  • Corticosteroid-responsive dermatoses
  • Cutaneous candidiasis
  • Cystic tumour of the ganglia
  • Exfoliative erythroderma
  • Granuloma annulare lesions
  • Idiopathic eosinophilic pneumonias
  • Non-suppurative Thyroiditis
  • Oral infections
  • Oral lesions
  • Severe Erythema multiforme
  • Subacute Dermatitis, Eczematous
  • Symptomatic Sarcoidosis
  • Ulceration of the mouth
  • Ulcerative stomatitis

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/06/24
N/A
Completed
Maharajgunj Medical Campus
2025/06/10
Phase 4
Active, not recruiting
Kasr El Aini Hospital
2025/06/05
Phase 4
Recruiting
2025/05/29
Phase 2
Active, not recruiting
2025/05/18
Phase 2
Not yet recruiting
2025/04/20
Phase 4
Not yet recruiting
2025/03/27
Phase 4
Not yet recruiting
Nishtar Medical University
2025/02/07
Phase 2
Active, not recruiting
2025/02/06
Phase 1
ENROLLING_BY_INVITATION
2025/01/29
Not Applicable
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Macleods Pharmaceuticals Limited
33342-329
TOPICAL
1 mg in 1 g
7/1/2023
NuCare Pharmaceuticals,Inc.
68071-2491
TOPICAL
1 mg in 1 g
8/4/2021
MICRO LABS LIMITED
42571-385
TOPICAL
1 mg in 1 mL
8/10/2021
Alembic Pharmaceuticals Inc.
62332-606
TOPICAL
1 mg in 1 g
12/12/2023
Crown Laboratories
0316-0175
TOPICAL
5 mg in 1 g
10/24/2023
Bryant Ranch Prepack
63629-2495
TOPICAL
1 mg in 1 g
2/15/2022
Sincerus Florida, LLC
72934-2166
TOPICAL
0.1 g in 100 g
5/13/2019
NorthStar Rx LLC
16714-150
INTRA-ARTICULAR, INTRAMUSCULAR
400 mg in 10 mL
1/23/2024
Physicians Total Care, Inc.
54868-6270
NASAL
55 ug in 1 1
9/27/2011
Bryant Ranch Prepack
63629-2407
TOPICAL
0.147 mg in 1 g
2/23/2021

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
ECOCORT CREAM
SIN10246P
CREAM
0.1%w/w
10/9/1998
ORREPASTE 0.1% w/w
SIN11484P
PASTE
0.1% w/w
4/9/2001
ORACORT E DENTAL PASTE
SIN04682P
PASTE
0.1% w/w
6/13/1990
SHINCORT I.M. INJECTION 40 mg/ml
SIN05787P
INJECTION
40 mg/ml
4/26/1991
ORAMEDY PASTE 1 mg/g
SIN04004P
PASTE
1 mg/g
3/20/1990
SHINCORT INJECTION 10 mg/ml
SIN06709P
INJECTION
10 mg/ml
12/3/1991
KENO ORAL PASTE 1 mg/g
SIN11853P
PASTE
1 mg/g
3/21/2002
TRIAMCINOLONE ACETONIDE 40 mg/ml
SIN06648P
INJECTION
40 mg/ml
10/24/1991
NASACORT AQ NASAL SPRAY 55 mcg/actuation
SIN10821P
SPRAY
55 mcg/actuation
3/19/1999
ECONAZINE CREAM
SIN06601P
CREAM
1 mg/g
10/1/1991

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Triamcinolone Tablets
国药准字H10960056
化学药品
片剂
7/28/2020
Triamcinolone Acetonide Acetate And Chloramphenicol Solution
国药准字H13024373
化学药品
溶液剂
9/29/2020
Triamcinolone Acetonide Acetate Nasal Spray
国药准字H20030910
化学药品
喷雾剂
12/7/2020
Triamcinolone Acetonide Dental Paste
国药准字HC20181015
化学药品
软膏剂
3/16/2023
Triamcinolone Acetonide Acetate Injection
国药准字H33020762
化学药品
注射剂
4/26/2020
Triamcinolone Acetonide Acetate Injection
国药准字H33020825
化学药品
注射剂
4/26/2020
Triamcinolone Acetonide Acetate Injection
国药准字H12020607
化学药品
注射剂
7/27/2020
Triamcinolone Acetonide Acetate Injection
国药准字H12020606
化学药品
注射剂
7/27/2020
Triamcinolone Acetonide Acetate Injection
国药准字H20033524
化学药品
注射剂
4/26/2020
Triamcinolone Acetonide Acetate Injection
国药准字H33021092
化学药品
注射剂
4/26/2020
© Copyright 2025. All Rights Reserved by MedPath